Close Window

Digital Look Email A Friend

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

Published by Frank Prenesti on 23rd February 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

URL: http://www.digitallook.com/dl/news/story/33324007/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.